Honeywell said fourth-quarter net income rose to $369 million, or 47 cents a share, from $150 million, or 20 cents a share, in the prior year. Excluding special items, earnings were 87 cents a share in the fourth quarter. Fourth-quarter sales increased 12% to $9 billion from $8.1 billion a year ago. On average, analyst swere expecting Honeywell to report earnings of 87 cents a share on revenue of $8.84 billion. Shares of the company fell 1.1% to $55.30.
Sara Lee ( SLE) said it will split the company into two separate, publicly traded companies. Under the plan, Sara Lee's North American Retail and North American Foodservice businesses, excluding the North American beverage business, will be spun off into a new, public company that will retain the Sara Lee name. The other company, which doesn't have a name yet, will consist of Sara Lee's International Beverage and Bakery businesses and the North American beverage business. Sara Lee's board plans to declare a special dividend of $3 a share on the company's common stock along with the split. The split should be completed in early calendar year 2012. Sara Lee shares rose 0.3% to $17.69.
Highlighting strength in its business and entertainment divisions, Microsoft ( MSFT) posted way-better-than-expected second-quarter earnings on Thursday. Shares of the company were flat at $28.85 in premarket trading.
Chevron ( CVX) is expected to report fourth-quarter earnings of $2.40 a share on revenue of $55.97 billion. During the same time last year, the company reported earnings of $1.53 a share on revenue of $48.68 billion. One area of focus will be how the company has been dealing with energy cost inflation. Shares of Chevron rose 0.4% to $95.15.
Amazon ( AMZN) reported a revenue shortfall in its fiscal fourth quarter. Shares of Amazon fell 7.6% to $170.52.
Verizon Communications ( VZ) showed it's serious about making an aggressive push into cloud computing Thursday, agreeing to acquire Terremark Worldwide ( TMRK) for $1.4 billion in cash. Verizon fell 0.8% to $36.20, while Terremark surged by 36.2% to $19.14 in premarket trading Friday.
Sanofi-Aventis ( SNY) shares fell Friday after its cancer drug iniparib didn't meet primary endpoints of overall survival and progression-free survival for breast cancer patients. Sanofi-Aventis dropped 4.2% to $33.78.
>>Search for Highest Dividends by Rate or Yield
|More on Earnings Today's Top Earnings|